PIK3CA and colonic neoplasm: Direct sequencing of the hot spot regions at exons 9 and 20 of Pik3ca in the colonic tumors validated our GEM model as a surrogate for PIK3CA wild-type CRC, which we used in our in vivo NVP-BEZ235 treatment studies.